drugset / Trial / NCT01752985
Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether BMS-813160 will reduce the amount of protein loss in the urine of subjects with type 2 diabetes and diabetic kidney disease
Timeline
- Start
- 2013-03-18
- Primary completion
- 2015-06-30
- Completion
- 2015-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-813160 | Small molecule | 150 mg | Oral |
| Subject | BMS-813160 | Small molecule | 300 mg | Oral |